Effectiveness of Implementing Antibiotic Treatment Guidelines for Febrile Neutropenia in Adults at Siriraj Hospital

Effectiveness of Implementing Antibiotic Treatment Guidelines for Febrile Neutropenia in Adults at Siriraj Hospital - Guidelines for febrile neutropenia

Status

Active, not recruiting

Phases

Phase 3

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300078940

Enrollment

Unknown

Registered

2023-12-21

Start date

2024-01-01

Completion date

Unknown

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Febrile neutropenia

Interventions

Before implementation:No guideline implementation

After implementation:Guideline implementation

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adult patients (>18 years old) with febrile neutropenia following chemotherapy 2. Hospitalized at Siriraj Hospital (Bangkok, Thailand) in retrospective period (Nov 2022 to Oct 2023) and prospective period (Jan 2024 to Dec 2024)

Exclusion criteria

Exclusion criteria: Patients without available data for analysis

Design outcomes

Primary

Measure	Time frame
Duration of empiric antibiotic in patients with unexplained febrile neutropenia ;	—

Secondary

Measure	Time frame
Proportion of empirical vancomycin ;Composite outcome;	—

Countries

Thailand

Contacts

Public ContactRujipas Sirijatuphat

Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand

rujipas.sir@mahidol.ac.th+66 2 419 7783

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026